SEC Comment Letter for REGEN BIOLOGICS INC (CIK 0000883697) — Jun 16, 2005
REGEN BIOLOGICS INC (CIK 0000883697)
Date: June 16, 2005 · CIK: 0000883697 · Accession: 0000000000-05-030501
AI Filing Summary & Sentiment
File numbers found in text: 000-20805
Letter
Mail Stop 03-06 June 17, 2005 Brion Umidi Chief Financial Officer ReGen Biologics, Inc 509 Commerce Street 1st Floor, East Wing Franklin Lakes, NJ 07417
Re: ReGen Biologics, Inc. Form 10-K for year ended December 31, 2004 Filed March 28, 2005 File No. 000-20805
Dear Mr. Umidi:
We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments.
Sincerely,
Martin F. James
Senior Assistant Chief Accountant
Show Raw Text
<DOCUMENT> <TYPE>LETTER <SEQUENCE>1 <FILENAME>filename1.txt <TEXT> Mail Stop 03-06 June 17, 2005 Brion Umidi Chief Financial Officer ReGen Biologics, Inc 509 Commerce Street 1st Floor, East Wing Franklin Lakes, NJ 07417 Re: ReGen Biologics, Inc. Form 10-K for year ended December 31, 2004 Filed March 28, 2005 File No. 000-20805 Dear Mr. Umidi: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. Sincerely, Martin F. James Senior Assistant Chief Accountant </TEXT> </DOCUMENT>